Me kēia huaʻōlelo i ka noʻonoʻo, ua lilo mākou i hoʻokahi o nā mea hana ʻenehana hou loa, ʻoi aku ka maikaʻi, a me nā kumu hoʻokūkū hoʻokūkū no Trending Products Medicine Grade Celery Seed Extract 98% Apigenin, Manaʻolana maoli e kūkulu i nā pilina ʻoihana lōʻihi. me ʻoe a e hana mākou i kā mākou hui maikaʻi loa i kāu hihia.
Me kēia huaʻōlelo i ka noʻonoʻo, ua lilo maoli mākou i hoʻokahi o nā mea hana ʻenehana hou loa, ʻoi aku ka maikaʻi, a me ka hoʻokūkū kumu kūʻai.ʻO Apigenin, Pākuʻi Apigenin, No ka ʻoi aku o ʻumi mau makahiki i ka ʻike ma kēia waiho ʻana, ua loaʻa i kā mākou hui ka inoa kiʻekiʻe mai ka home a ma waho.No laila ke hoʻokipa nei mākou i nā hoaaloha mai nā wahi a pau e hele mai e hoʻopili iā mākou, ʻaʻole wale no ka ʻoihana, akā no ka pilina.
Ua hōʻike ʻia ʻo Apigenin, ma ke ʻano he bioflavonoid i ʻike ʻia, e hōʻike i nā hana olaola like ʻole, me ka antioxidant, anti-inflammatory, antitumor, ant-genotoxic, anti-allergic, neuroprotective, cardioprotective, a me antimicrobial. ʻO ka celery (Apium graveolens), he mea kanu marsh ma ka ʻohana Apiaceae i mahi ʻia ma ke ʻano he mea kanu mai ka wā kahiko.ʻO Apigenin ka meaʻai nui loa i unuhiʻia i ka celery, aia ka 108 mg apigenin i ka kg.ʻO Apigenin kekahi o nā flavonoids meaʻai maʻamau, i loaʻa nui i nā huaʻai, nā mea kanu, a me nā lāʻau lapaʻau.Hoʻohana ia i nā hana physiological like ʻole, e like me antioxidant, potent anti-inflammatory, antiviral activities, antibacterial a me ke kahe koko.
Inoa mea kūʻai:He 98% ka wehe ʻana o ka lau Celery Apigenin
Inoa Latina: Apium graveolens L.
No CAS: 520-36-5
Māhele Mea kanu i hoʻohana ʻia:Leaf
Mea komo: Apigenin
ʻIke: Apigenin 98.0% na HPLC
Ka waihoʻoluʻu: ʻEleʻele a melemele ka pauka me ka ʻala a me ka ʻono
Kūlana GMO: ʻAʻole GMO
Hoʻopili: ma 25kgs fiber drums
Ka mālama ʻana: E mālama i ka pahu i wehe ʻole ʻia ma kahi maloʻo a maloʻo, e haʻalele i ka mālamalama ikaika
Ola Ola: 24 mahina mai ka lā i hana ʻia
Ka hopena anti-tumor
He kuleana koʻikoʻi ka Apigenin i ka pale ʻana i ka maʻi maʻi ma o ka hoʻoulu ʻana i ka apoptosis i nā laina kelepona like ʻole.
Ka maʻi 'ovarian:
Ua ʻike ʻia kekahi mau noiʻi e hiki i ka apigenin ke kāohi i ka ulu ʻana, ka hoʻonui ʻana, a me ka hoʻololi ʻana o ka ca-ov3 (ke kanaka ovarian cancer cell);hoʻoulu ʻo ia i ka apoptosis o ca-ov3 ma o ka mālama ʻana i nā maʻi maʻi maʻi i ka pae G2/M.Pili ka hopena i ka manawa a me ka nui.
ʻO ka maʻi maʻi pancreatic:
Hiki i ka Apigenin ke pale i ka hoʻonui ʻana o nā maʻi maʻi pancreatic.Pōloli ʻo Apigenin i ke koko ma o ka hoʻemi ʻana i ke kumu o ka glucose, ʻo ia ka meaʻai e ola ai nā maʻi kanesa.Ma waho aʻe, hiki i ka Apigenin ke hoʻomaikaʻi i ka maikaʻi o ka lāʻau chemotherapy- gemcitabine.
Kemo-naʻi
Ua ʻike ʻia ʻo ka apigenin i loko o ka haʻahaʻa haʻahaʻa he hopena cytotoxic haʻahaʻa a ʻaʻole hiki ke hoʻoulu i ka maʻi leukemia myeloid acute kanaka (hl-60) i ka apoptosis pono.Eia naʻe, hiki i ka apigenin ke hoʻonui i ka hopena o ka cisplatin (DDP) ma ka hl-60 cell proliferation me ka hui pū me nā manaʻo likeʻole o DDP.No laila hiki i ka Apigenin ke loaʻa ka hopena chemotherapy-sensitization ma hl-60;Hiki i nā haʻahaʻa haʻahaʻa o apigenin ke hoʻemi i ke kūʻē ʻana o nā cell hl-60 i ka apoptosis i hoʻokomo ʻia i ka chemotherapy, pili paha i ka hoʻoponopono iho o NF-κB a me BCL-2.(NF-KB he ʻano protein complex e hoʻomalu ana i ka palapala DNA, ka hana ʻana o nā cytokines a me ke ola o nā cell; Hoʻopili ʻia ʻo BCL-2 i ke kino ma o ka BCL2 gene, ʻo ia ka lālā kumu o ka ʻohana protein regulatory BCL-2. hiki ke hoʻoponopono i ka make cell)
Ka mālama ʻana i ke ake
Hiki i ka Apigenin ke hōʻemi i ka ʻeha o ka ate i hoʻoulu ʻia e ka ischemia-reperfusion ma o ka antagonizing lipid peroxidation a me ka scavenging free radical.
Hiki i ka Apigenin ke hōʻemi i ka ʻeha o ka ate ma muli o ke koʻikoʻi oxidative ma muli o kāna mau hana antioxidant a me nā hana anti-inflammatory.
Ua hōʻike nā hoʻokolohua lāʻau lapaʻau he hopena palekana ko apigenin i ka ʻeha o ka ate / hepatocyte i hoʻokomo ʻia i ka waiʻona, a ʻo kāna ʻano kumu mua e pili ana i ka pale ʻana i ka ʻōlelo CYP2E1 i loko o ke ake / hepatocyte.
Kāohi i ka osteoporosis
Kāohi ʻo Apigenin i ka osteoblastogenesis, osteoclastogenesis, a pale pū i ka nalo iwi.
Mālama ʻo Apigenin i ka ʻiʻo iwi ma ka hōʻemi ʻana i ka nalowale o ka iwi ma ke kino.
ʻO kekahi mau haʻawina e pili ana i ka MC3T3-E1, he osteoblast precursor cell line i loaʻa mai Mus musculus (mouse) calvaria, ua ʻike ʻo apigenin hiki ke kāohi i ka TNF-α, IFN-γ, a laila hoʻoulu i ka huna ʻana o kekahi mau cytokines e hoʻoikaika i ka hoʻokumu osteoclast.
Apigenin no hoi i keakea i ka differentiation o 3T3-L1 adipose precursor pūnaewele i adipocytes ikaika, no laila, inhibiting ka differentiation attendant inhibition adipocyte differentiation-induced IL-6, MCP-1, lectin huahana.
Hoʻopili ʻo Apigenin i ka hoʻokaʻawale ʻana o nā osteoclast mai RAW264.7 laina kelepona a laila keʻakeʻa i ka hoʻokumu ʻana o nā osteoclast multinucleated.Hiki iā ia ke hoʻoulu i ka apoptosis osteoclast a keʻakeʻa i ka resorption iwi.
Ka hana anti-inflammatory a me ka anti-oxidant
Hoʻopaʻa ʻo Apigenin i ke kaʻina hana ʻona, hoʻonui i nā pae IL-10 a hoʻomaʻamaʻa i nā ʻāpana koʻikoʻi oxidative.
Kāohi ʻo Apigenin i nā cytokine pro-inflammatory a hoʻoulu i ka hana anti-inflammatory cytokine.
Ke hōʻike nei kekahi mau palapala e hoʻopau ka apigenin i ka ʻāʻī o ka ʻiʻo i hoʻoulu ʻia e ke koʻikoʻi oxidative i loko o nā ʻiʻo ma o ka hoʻololi ʻana i nā hōʻailona koʻikoʻi oxidative, interleukins, nā hōʻailona enzyme koko, a me ka hōʻike ʻana o kekahi mau enzyme pili.
Hoʻoponopono i ka endocrine
Hiki i ka Apigenin ke hoʻoponopono i ke kō koko, mālama i ka lawaʻole o ka thyroid a mālama i ka lipid peroxidation. 6-Pase).
Ua hoʻohuli ʻo Apigenin i nā hopena o ka hoʻonui ʻana i ka cholesterol serum, hoʻonui i ka ate lipid peroxidation (LPO) a hoʻemi i nā hana o nā antioxidants e like me catalase (CAT) a me superoxide dismutase (SOD) i nā holoholona alloxan-induced.
I nā holoholona me ke kō koko maʻamau, hiki i ka apigenin ke hoʻemi i ka cholesterol serum a me ka lipid peroxidation ate, a hoʻonui i ka hana o nā antioxidants i nā cell.
Nā waiwai pharmacological o apigenin
Ua hoʻopili nui ʻia ʻo Apigenin i nā makahiki i hala iho nei, ma ke ʻano he mea hoʻolaha olakino maikaʻi ma muli o ka haʻahaʻa o ka ʻawaʻawa a me kona hopena olakino i nā maʻi maʻi maʻi maʻamau, i hoʻohālikelike ʻia me nā flavonoids e pili ana i ke ʻano.Aia ka nui o nā hōʻike noiʻi e hōʻike ana i ka apigenin he mea lapaʻau nui no nā maʻi he nui
Hana:
-Kaohi i ka ulu ana o na ma'i ma'i.
-E hoʻohaʻahaʻa i ke koko
- Mālama i ka ʻōnaehana cardiovascular
- Kōkua i ka hiamoe, hoʻomaha i nā aʻalolo, hoʻopau i ka huhū
-E pale i ka mumū
-E pale i ka osteoporosis
- Ka hopena diuretic.
-Kāʻe i ka platelet aggregation.
Noi:
-Mahele lāʻau lapaʻau, kahua mālama ola kino
ʻIke hou aku o TRB | ||
Rpalapala hōʻoia egulation | ||
USFDA, CEP, KOSHER HALAL GMP ISO palapala | ||
Pono Pono | ||
Ma kahi kokoke i 20 mau makahiki, hoʻokuʻu aku i 40 mau ʻāina a me nā ʻāina, ʻoi aku ma mua o 2000 mau pahu i hana ʻia e TRB ʻaʻohe pilikia maikaʻi, ke kaʻina hana hoʻomaʻemaʻe kūʻokoʻa, ka haumia a me ka hoʻomaʻemaʻe ʻana e hui pū me USP, EP a me CP | ||
Pūnaehana Kūlana piha | ||
| ▲ Pūnaehana hōʻoia maikaʻi | √ |
▲ Ka mālama palapala | √ | |
▲ Pūnaehana Hōʻoia | √ | |
▲ Pūnaehana hoʻomaʻamaʻa | √ | |
▲ Hoʻoponopono Kūloko | √ | |
▲ Pūnaehana Hoʻopono Hoʻohui | √ | |
▲ Pūnaehana lako lako | √ | |
▲ Pūnaehana Mana Mana | √ | |
▲ Pūnaehana Mana Hana | √ | |
▲ Pūnaehana Lepili Packaging | √ | |
▲ Pūnaehana Mana Mana | √ | |
▲ Pūnaehana hōʻoia hōʻoia | √ | |
▲ Pūnaehana Hoʻoponopono | √ | |
E mālama i nā kumu a me nā kaʻina hana | ||
Hoʻomalu pono i nā mea maka a pau, nā mea hana a me nā mea hoʻopili. | ||
ʻO nā hui hui ikaika e kākoʻo | ||
Institute of botany/Institution of microbiology/Academy of Science and Technology/University |